Showing results (161-170 of 222) with videos related to
Sort By:
Pageof 23
BMJ Open|April 3, 2012
Incident user cohort study of risk for gastrointestinal bleed and stroke in individuals with major depressive disorder treated with antidepressantsVictor M Castro, Patience J Gallagher, Caitlin C Clements, et al.Journal of Affective Disorders|January 24, 2006
The detection of depression in medical setting: a study with PRIME-MDRenerio Fraguas, Sergio Gonsalves Henriques, Sergio Gonsalves Henriques, et al.Journal of Affective Disorders|September 9, 2019
Time to relapse after a single administration of intravenous ketamine augmentation in unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Rebecca S Hock, et al.Depression and Anxiety|January 1, 2019
Efficacy of intravenous ketamine treatment in anxious versus nonanxious unipolar treatment-resistant depressionNaji C Salloum, Maurizio Fava, Marlene P Freeman, et al.The Journal of Clinical Psychiatry|November 16, 2022
Effect of Concomitant Benzodiazepines on the Antidepressant Effects of Ketamine: Findings From the RAPID Intravenous Ketamine StudyAnna Feeney, Bettina B Hoeppner, Marlene P Freeman, et al.Clinical Trials (London, England)|November 26, 2009
Lithium treatment -- moderate dose use study (LiTMUS) for bipolar disorder: rationale and designAndrew A Nierenberg, Louisa G Sylvia, Andrew C Leon, et al.Biological Psychiatry|August 12, 2014
Illness progression, recent stress, and morphometry of hippocampal subfields and medial prefrontal cortex in major depressionMichael T Treadway, Michael L Waskom, Daniel G Dillon, et al.Chronic Stress (Thousand Oaks, Calif.)|May 23, 2020
Initial Evidence for Brain Plasticity Following a Digital Therapeutic Intervention for DepressionMegan M Hoch, Gaelle E Doucet, Dominik A Moser, et al.The American Journal of Psychiatry|January 5, 2013
Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithiumAndrew A Nierenberg, Edward S Friedman, Charles L Bowden, et al.CNS Spectrums|July 14, 2012
Prevalence of MTHFR C677T and MS A2756G polymorphisms in major depressive disorder, and their impact on response to fluoxetine treatmentDavid Mischoulon, Stefania Lamon-Fava, Jacob Selhub, et al.Pageof 23